Patients missing out on arthritis drugs, shows study

A class of drugs that has been successfully treating patients with severe rheumatoid arthritis should be made available for moderate suffers, too, University of Manchester scientists say. A study led by Dr. James Gwinnutt reveals that some rheumatoid arthritis patients who do not qualify for biological treatments on the NHS have high levels of disability caused by the condition. It […]

Read more

Opioid crisis burning out doctors, study finds

As the opioid crisis take a deadly toll in human lives, the complex needs of patients in chronic pain are also leaving their doctors increasingly exhausted and overwhelmed, a new Western-led study says. In their detailed interviews and clinic observations, researchers found many primary-care physicians are close to burnout in caring for patients in pain. “You are in between a […]

Read more

New drug mimics benefits of ketamine for depression

A new small-molecule drug produced a rapid antidepressant response similar to that of ketamine when tested in mice, a new Yale-led study published April 16 in the Journal of Clinical Investigation shows. The effects of the drug, called NV-5138, in rodent models mimicked the rapid actions of the anesthetic ketamine, a variation of which, Esketamine, was recently approved by the […]

Read more

FDA approves mavenclad for treating multiple sclerosis

(HealthDay)—Mavenclad (cladribine) tablets were approved to treat adult patients with relapsing-remitting and active secondary progressive multiple sclerosis (MS) who have inadequately responded to or cannot tolerate an alternate drug for MS, the U.S. Food and Drug Administration announced Friday. The approval was based on efficacy data from a clinical trial of 1,326 patients with relapsing forms of MS who had […]

Read more

Group with consumer-friendly vibe pushes drugmakers’ message

Outside groups like the Alliance for Patient Access are raising their voices as they seek to influence deliberations in Washington aimed at lowering prescription drug costs. But not all of these organizations are clear about who they actually represent. Their names can obscure the source of the message and they’re cagey about where their money comes from. The Alliance is […]

Read more

Ketamine-based nasal spray to treat depression

The FDA recently approved a ketamine-based drug to assist with treating depression. The new medication, Spravato, is an intranasal spray that can help those suffering with extreme depression who see little results with psychiatric medications. A Baylor College of Medicine expert discussed the potential impact of the new treatment, which is being marketed as the first fast-acting depression drug. “Ketamine […]

Read more

Many antibiotic courses for common infections not in line with guidelines

Many antibiotic courses prescribed for common infections treated in English primary care (general practices and community services) exceed the recommended guidelines, reveals a study in The BMJ today. Treatment courses were 1.3 million days beyond the durations recommended by guidelines, with most excess days due to treatment for respiratory conditions. Previous studies have found significant over-prescribing of antibiotics in primary […]

Read more
1 2 3 4